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Table 1













.05 5,013 4,971 5,072 11,115 11,089
.01 970 968 1,034 3,678 3,678
.001 103 107 114 797 813
.0001 10 7 11 206 209
.00001 0 0 1 51 54
.000001 0 0 1 16 17
niﬁcantly between cases and controls, the correct ap-
proach is to perform a heterogeneity test, in which one
calculates whether the overall likelihood is signiﬁcantly
higher if different frequencies are allowed than if the
same frequencies apply to both groups. An incorrect
approach is to estimate haplotype counts by multiplying
the frequencies by twice the sample size and then to treat
these counts as if they were actually observed. The
counts may be compared using a Pearson x2 test on a
contingency table, by a permutation test as implemented
in the CLUMP program (Sham and Curtis 1995) or by
the newly described entropy method (Zhao et al. 2005).
In every case, the test based on estimated counts will be
anticonservative.
To illustrate that this is the case, we randomly gen-
erated case-control samples genotyped for two markers,
assuming that the population frequencies of the haplo-
types were the same for all subjects, under the assump-
tion of random mating. For each data set, we applied a
Pearson x2 test and the entropy test to the counts of the
simulated haplotypes. We then combined pairs of hap-
lotypes into two-locus genotypes, and we used the
GENECOUNTING program (Zhao et al. 2002) to ob-
tain estimated haplotype frequencies in the cases, con-
trols, and combined sample, along with the associated
likelihoods. We applied a heterogeneity test to these like-
lihoods and again applied the Pearson x2 and entropy
tests, this time to the estimated counts. Illustrative results
are given in table 1, for which the population frequencies
of the four haplotypes were set at 0.5, 0.2, 0.2, and 0.1,
and a sample size of 500 cases and 500 controls was
used. The Pearson x2 and entropy tests perform appro-
priately when applied to the actual haplotype counts, as
does the heterogeneity test using likelihoods based on
estimated frequencies. However, both of the tests that
use estimated counts are markedly anticonservative.
It is not appropriate to treat estimated haplotypes as
if they were observed, and tests that do so will produce
unacceptably high type I error rates. As we have said,
this will apply even if a permutation test is performed
on the estimated haplotypes—for example, by inputting
them into the CLUMP program (Sham and Curtis 1995).
However, a valid test can be devised if, instead, the orig-
inal data are repeatedly permuted and then, for each
permuted data set, haplotypes are estimated and a test
statistic is derived. The rank of the test statistic obtained
from the original data set can then be used to obtain an
empirical signiﬁcance level (North et al. 2003), and such
an approach could be used for the entropy-based sta-
tistic. Without such a permutation procedure, we do not
see how the entropy test can be applied to case-control
data.
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Reply to Wirtenberger et al.
To the Editor:
Wirtenberger et al. (2006) analyzed the SNP content of
82 large (median length 157 kb) common copy-number
polymorphisms (CNPs), selected from the Database of
Genomic Variations, and determined the number of
SNPs included in the GeneChip Mapping 100K arrays
(Affymetrix). The data they presented showed that the
density of these SNPs within the CNPs is lower than
would be expected, with 52.4% of CNPs having no SNP
coverage (median length 120 kb) and only 8.5% having
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a SNP density equal to or higher than the overall mean
intermarker density for all SNPs on the array.
As suggested by Wirtenberger et al. (2006), the un-
derlying reason for this low density of Mapping 100K
SNPs in their selected CNPs is the selection criteria used
for SNPs on the array. The SNP selection criteria for the
Mapping 100K arrays select strongly but not completely
against SNPs in segmental duplications. The selection is
based on genotyping accuracy, Mendelian inheritance,
Hardy-Weinberg equilibrium, robustness, and repro-
ducibility—all of which are characteristics likely to give
poor results in genotyping SNPs that are located in
CNPs. Despite a selective bias against SNPs in CNPs,
some SNPs on the Mapping 100K arrays are able to
provide CNP information. For example, asWirtenberger
et al. (2006) indicate, 14.6% of the CNP regions con-
tained more than four of the SNPs on the array.
Even with modiﬁcations in SNP selection, the current
algorithm implemented in CNAT (Affymetrix) would
still need to be modiﬁed, because it compares copy-
number data from the test sample with data from a large
pool of normal reference individuals, thereby decreasing
the likelihood of detecting CNPs. Future advances in
SNP selection, algorithm development, and density will
be required to identify frequent CNPs by use of SNP
arrays.
For investigation of CNPs, the advice of Wirtenberger
et al. (2006) to be aware of the limitation of Mapping
100K microarrays is sound. However, it is worth re-
membering that we (Slater et al. [2005]) describe their
use for detection of clinically signiﬁcant chromosome
abnormalities. Exclusion of SNPs within common CNPs
is arguably an advantage in the diagnostic scenariowhen
virtually nothing is currently known of the clinical sig-
niﬁcance of these CNPs.
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